Pathstone Family Office
CELG

Pathstone Family Office’s Celgene Corp CELG Stock Holding History

Pathstone Family Office’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$99K – 689
2019
Q3 		$99K Sell
1,000
-100
-9% -$9.5K 0.01% 197
2019
Q2 		$101K Sell
1,100
-450
-29% -$42.7K 0.01% 257
2019
Q1 		$145K Buy
1,550
+1,450
+1,450% +$127K 0.02% 199
2018
Q4 		$6K Hold
100
– – ﹤0.01% 369
2018
Q3 		$9K Buy
+100
New +$8.84K ﹤0.01% 165
2018
Q2 		– Sell
-119
Closed -$11K – 379
2018
Q1 		$11K Hold
119
– – 0.01% 219
2017
Q4 		$12K Sell
119
-116
-49% -$13.1K 0.01% 104
2017
Q3 		$35K Buy
235
+81
+53% +$11K 0.03% 84
2017
Q2 		$20K Sell
154
-130
-46% -$15.9K 0.01% 280
2017
Q1 		$35K Buy
+284
New +$34K 0.02% 204
2016
Q4 		– Sell
-459
Closed -$47K – 238
2016
Q3 		$47K Buy
459
+274
+148% +$29.7K 0.05% 65
2016
Q2 		$18K Buy
185
+135
+270% +$14K 0.02% 97
2016
Q1 		$5K Buy
+50
New +$5.15K 0.01% 151
2015
Q4 		– Sell
-50
Closed -$5K – 185
2015
Q3 		$5K Buy
+50
New +$6.2K 0.01% 127
2014
Q4 		– Sell
-280
Closed -$27K – 333
2014
Q3 		$27K Buy
+280
New +$25.3K 0.08% 98

Other funds holding CELG

Howard Capital Management
Howard Capital Management Roswell, Georgia $8.26B AUM 36.73% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $514M AUM 11.69% 1-Year Est. Return

Pathstone Family Office's CELG Position: Q4 2019 in Review

Pathstone Family Office sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,000 shares — an estimated $99K sold.

Pathstone Family Office first reported a position in CELG in Q3 2014 and held it in 15 quarters. The position peaked at $145K in Q1 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Pathstone Family Office reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Pathstone Family Office sold 1,000 Celgene Corp shares in Q4 2019, an estimated $99K.
  • Pathstone Family Office first reported a position in Celgene Corp in Q3 2014 and held it in 15 quarters.
  • Pathstone Family Office's Celgene Corp position peaked at $145K in Q1 2019.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pathstone Family Office's 13F filing for Q4 2019, filed 14 Feb 2020.